Marshall Wace
REPL icon

Marshall Wace’s Replimune Group REPL Stock Holding History

Marshall Wace’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-93,585
Closed -$910K – 3607
2025
Q4 		$910K Buy
+93,585
New +$796K ﹤0.01% 1983
2025
Q3 		– Sell
-1,866,524
Closed -$17.3M – 3324
2025
Q2 		$17.3M Sell
1,866,524
-621,161
-25% -$5.42M 0.02% 640
2025
Q1 		$24.3M Buy
2,487,685
+1,591,501
+178% +$19.7M 0.03% 466
2024
Q4 		$10.9M Buy
+896,184
New +$10.9M 0.01% 767
2024
Q2 		– Sell
-16,581
Closed -$135K – 2884
2024
Q1 		$135K Sell
16,581
-80,253
-83% -$658K ﹤0.01% 2276
2023
Q4 		$816K Sell
96,834
-592,619
-86% -$6.87M ﹤0.01% 1541
2023
Q3 		$11.8M Sell
689,453
-543,771
-44% -$10.7M 0.02% 598
2023
Q2 		$28.6M Buy
1,233,224
+586,336
+91% +$11.5M 0.06% 361
2023
Q1 		$11.4M Buy
646,888
+520,321
+411% +$12.4M 0.02% 665
2022
Q4 		$3.44M Buy
+126,567
New +$2.63M 0.01% 1429
2022
Q2 		– Sell
-20,143
Closed -$342K – 3775
2022
Q1 		$342K Buy
+20,143
New +$380K ﹤0.01% 2929
2020
Q4 		– Sell
-21,291
Closed -$490K – 2121
2020
Q3 		$490K Buy
21,291
+7,205
+51% +$164K ﹤0.01% 1253
2020
Q2 		$350K Buy
+14,086
New +$249K ﹤0.01% 1292
2020
Q1 		– Sell
-12,311
Closed -$177K – 1993
2019
Q4 		$177K Buy
+12,311
New +$177K ﹤0.01% 1365

Other funds holding REPL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Marshall Wace's REPL Position: Q1 2026 in Review

Marshall Wace sold out of Replimune Group (REPL) in Q1 2026, closing a stake of 93,585 shares — an estimated $910K sold.

Marshall Wace first reported a position in REPL in Q4 2019 and held it in 14 quarters. The position peaked at $28.6M in Q2 2023. 180 funds tracked by Wall St. Rank hold REPL as of Q1 2026.

  • Marshall Wace reported no remaining Replimune Group position as of Q1 2026 after selling out during the quarter.
  • Marshall Wace sold 93,585 Replimune Group shares in Q1 2026, an estimated $910K.
  • Marshall Wace first reported a position in Replimune Group in Q4 2019 and held it in 14 quarters.
  • Marshall Wace's Replimune Group position peaked at $28.6M in Q2 2023.
  • 180 funds tracked by Wall St. Rank held Replimune Group as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.